كل ما تود معرفته عن BioNTech

U.S. FDA, CDC See Early Signal of Possible Pfizer Bivalent COVID Shot Link to Stroke

A safety monitoring system flagged that U.S. drugmaker Pfizer Inc (PFE.N) and German partner BioNTech's updated COVID-19 shot could be linked to a type of brain stroke in older adults, according to…

15 January 2023

A vial of the Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., September 8, 2022. REUTERS/Hannah Beier/File Photo

Pfizer/BioNTech Seek FDA Nod For New COVID Boosters For Children

Pfizer Inc (PFE.N) and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through…

26 September 2022

A healthcare worker prepares to administer a Pfizer/BioNTEch coronavirus disease (Covid-19) vaccine at The Michener Institute, in Toronto, Ontario on December 14, 2020. - Ontario, Canada's most populous province and one of the hardest hit by the pandemic, had 1,940 new cases and 23 deaths on Monday. The province is expected to give its next doses to nursing home workers as a priority, according to media reports. (Photo by CARLOS OSORIO / POOL / AFP) (Photo by CARLOS OSORIO/POOL/AFP via Getty Images)

Here’s Why the FDA Shouldn’t Rush Giving Full Approval to the COVID Vaccines

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

Michael Hiltzik 25 July 2021

Popular
Editor's Pick

Eduardo Ramon

Politics

The Houthis: the final battle?

06 August 2026

Regional and global players have begun to realise that the threat posed by the Yemeni militant group requires comprehensive and decisive action

Al Majalla - London

Opinion

Finding an effective strategy to combat Iran and its 'axis'

03 August 2026

Regional states have come to the realisation that fighting 'axis' members individually will have little effect, and any tactical success will likely be short-lived

Ibrahim Hamidi